SRSF1 Protein, Human (His-SUMO)

Customer Review

Based on 1 Customer Validation

The SRSF1 protein plays a crucial role in splicing regulation, preventing exon skipping and ensuring splicing accuracy. It interacts with spliceosome components and forms a bridge between 5'- and 3'-splice site binding elements. SRSF1 Protein, Human (His-SUMO) is the recombinant human-derived SRSF1 protein, expressed by E. coli , with N-SUMO, N-6*His labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: E. coli
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

The SRSF1 protein plays a crucial role in splicing regulation, preventing exon skipping and ensuring splicing accuracy. It interacts with spliceosome components and forms a bridge between 5'- and 3'-splice site binding elements. SRSF1 Protein, Human (His-SUMO) is the recombinant human-derived SRSF1 protein, expressed by E. coli , with N-SUMO, N-6*His labeled tag.

Background

SRSF1 protein plays a crucial role in maintaining splicing fidelity by preventing exon skipping and regulating alternative splicing. Its interaction with spliceosomal components, facilitated by RS domains, establishes a bridge between the 5'- and 3'-splice site binding elements, U1 snRNP and U2AF. SRSF1 exhibits preferential binding to purine-rich RNA sequences, acting as a splicing enhancer in vitro through the ASF/SF2 splicing enhancer (ASE). While isoforms ASF-2 and ASF-3 function as splicing repressors, SRSF1 may also serve as an export adapter in mRNA nuclear export via the TAP/NXF1 pathway. Within the spliceosome C complex, it collaborates with other RNA-binding proteins, including DDX5, HNRNPH2, and splicing regulator ARVCF. SRSF1's extensive interactome involves proteins such as SAFB/SAFB1, PSIP1/LEDGF, RSRC1, ZRSR2/U2AF1-RS2, CCDC55, SRPK1, NXF1, CCNL1, CCNL2, CDK11B, and RRP1B, showcasing its multifaceted roles in RNA processing and cellular functions. Additionally, its interaction with TNPO3 facilitates nuclear import when phosphorylated in the RS domain, and it interacts with ILDR1 and ILDR2.

Verified Bioactivity

Measured by its binding ability in a functional ELISA. Immobilized Human SRSF1, at 2 μg/mL (100μL/well) can bind Anti-SRSF1 antibody. The ED50 for this effect is ≤6.802 ng/mL.

MCE Validation Data

  • Purity - SDS-PAGE

    Purity - SDS-PAGE

    ≥ 95%, as determined by reducing SDS-PAGE.

  • Bioactivity - ELISA

    Bioactivity - ELISA

    Measured by its binding ability in a functional ELISA. Immobilized Human SRSF1, at 2 μg/mL (100 μL/well) can bind Anti-SRSF1 antibody. The ED50 for this effect is 6.802 ng/mL.

Technical Parameters

  • Species Human
  • Source E. coli
  • Tag N-SUMO;N-6*His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • 6*His-SUMO
    • SRSF1 (S2-T248)
      Accession # Q07955
    • C-term
  • Protein Length

    Full Length of Isoform-1

  • Synonyms

    SRSF1; SR Splicing Factor 1; Prev. SFRS1; MGC5228; Serine/Arginine-Rich Splicing Factor 1; Splicing Factor, Arginine/Serine-Rich 1 (Splicing Factor 2, Alternate Splicing Factor), Isoform CRA_f; ASF; Serine And Arginine Rich Splicing Factor 1 Transcript Va

  • AA Sequence

    SGGGVIRGPAGNNDCRIYVGNLPPDIRTKDIEDVFYKYGAIRDIDLKNRRGGPPFAFVEFEDPRDAEDAVYGRDGYDYDGYRLRVEFPRSGRGTGRGGGGGGGGGAPRGRYGPPSRRSENRVVVSGLPPSGSWQDLKDHMREAGDVCYADVYRDGTGVVEFVRKEDMTYAVRKLDNTKFRSHEGETAYIRVKVDGPRSPSYGRSRSRSRSRSRSRSRSNSRSRSYSPRRSRGSPRYSPRHSRSRSRT

  • Predicted Molecular Mass

    38.8 kDa

  • Molecular Weight

    Approximately 43 kDa, based on SDS-PAGE under reducing conditions.

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder

Formulation

Lyophilized from a 0.22 μm filtered solution of 50 mM Tris-HCl, 200 mM NaCl, 0.1%SKL, pH 8.0.
Note: For SPR assay, please replace the buffer. Primary amine components (e.g., Tris, imidazole) can affect protein-coupled chips.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00